- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03114345
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient (VASCIP)
December 8, 2021 updated by: University Hospital, Montpellier
Paraplegic patients have defective wound healing for sore below the level of spinal lesion.
Defect of vascularization of the healing zone certainly participate to this effect.
Therefore, this study want to measure, in a clinical settings, the interface pressure (e.g. the pressure between the patient body and the surface he/she is lying on) to assess the correlation between mechanical stress in term of pressure applied over time and tissue oxygenation which represent micro-vascular function.
The aim of this clinical trial is to correlate the variations of pressure intensities and changes in micro-vascularization.
The measure are recorded when paraplegic patient came into the hospital for pressure ulcer related surgery.
The patient is laying on his/her mattress on top of a flexible pressure mapping device.
The micro-vascularization parameters are measured at the area displaying the peak pressure a few minutes after the beginning of the pressure interface recording and one hour later at the same area.
The data generated during this monocentric study will help to achieve a better understanding of the relation between pressure and micro-vascularization.
In the mid term, it will provide a better and more patient adapted pressure ulcer prevention.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Languedoc-Roussillon
-
Montpellier, Languedoc-Roussillon, France, 34295
- University Regional Hospital Lapeyronie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Educated consent signed,
- Older than 18,
- Paraplegia for at least 6 months,
- Surgery planned for pressure ulcer resection,
Exclusion Criteria:
- Dementia,
- Stade IV arteritis non-revascularisable,
- Patient with no health insurance,
- Pregnant women or breast-feeding, patient unable to give his or her educated consent, ward of the state (art. L.1121-6, L.1121-7, L.1211-8, L.1211-9),
- Patient taking part in another study which could impact the local micro-vascularization.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Single arm
Measurement of interface pressure and Measurement of micro-vascularization related parameters
|
A capacitive pressure mapping device (XSensor) is set up on the patient air mattress bed.
It records the interface pressure on the whole patient body with one frame every second during one hour.
Then the file is saved and the pressure mapping device is removed from the patient hospital bedroom.
A medical device called O2C, measuring micro-vascularization related parameters (oxygen saturation, hemoglobin quantity and blood flow) is used.
The probe (= an optic fibre) is set up lightly on the patient skin or on a transparent adhesive for 1 minute.
The median value of the local micro-vascularization parameters are saved on the O2C interface.
The location of the measurement is chosen using the pressure mapping device to locate peak pressure area.
Then the O2C is removed from the patient hospital bedroom.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure of the pressure intensity in one area
Time Frame: Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
|
Pressure intensity is recorded using a mapping pressure device (XSensor), set up on the patient hospital bed.
Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device.
All measure are non-invasive.
|
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
|
Measure of the hemoglobin quantity in the same area
Time Frame: Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
|
Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device.
All measure are non-invasive.
|
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure of other micro-vascularization related parameters (such as the oxygen saturation and the blood flow) recorded at the same area.
Time Frame: Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
|
All micro-vascularization related parameters are measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device.
All measure are non-invasive.
|
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stefan Matecki, M.D., CHU de Montpellier
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 22, 2017
Primary Completion (ACTUAL)
November 22, 2019
Study Completion (ACTUAL)
November 22, 2019
Study Registration Dates
First Submitted
March 30, 2017
First Submitted That Met QC Criteria
April 10, 2017
First Posted (ACTUAL)
April 14, 2017
Study Record Updates
Last Update Posted (ACTUAL)
December 9, 2021
Last Update Submitted That Met QC Criteria
December 8, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9830
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injury
-
Taipei Veterans General Hospital, TaiwanThe Industrial Technology Research InstituteUnknownSpinal Cord Injuries | Complete Spinal Cord Injury | Incomplete Spinal Cord InjuryTaiwan
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingSCI - Spinal Cord Injury | Incomplete Spinal Cord InjuryUnited States
-
Jill M. Wecht, Ed.D.Icahn School of Medicine at Mount SinaiRecruitingBlood Pressure | Spinal Cord Injuries | SCI - Spinal Cord Injury | Blood Pressure Disorders | Traumatic Spinal Cord Injury | Acute Spinal Cord Injury | Neuromodulation | Spinal Cord StimulationUnited States
-
NervGen PharmaRecruitingSpinal Cord Injuries | Chronic Spinal Cord Injury | Subacute Spinal Cord InjuryUnited States
-
MetroHealth Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS); Case Western...RecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury CervicalUnited States
-
Kevin KilgoreNational Institute of Neurological Disorders and Stroke (NINDS); Case Western... and other collaboratorsRecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury Cervical | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C5-C7 Level With Incomplete LesionUnited States
-
The University of Texas Health Science Center,...TerminatedSpinal Cord Injuries | Cervical Spinal Cord Injury | Traumatic Spinal Cord CompressionUnited States
-
S.Biomedics Co., Ltd.Yonsei University; Linical Co., Ltd.RecruitingSpinal Cord Injury, Acute | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C4 Level With Complete LesionKorea, Republic of
-
StemCells, Inc.TerminatedStudy of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord InjuryCervical Spinal Cord Injury | Spine Injury | Cervical Spine InjuryUnited States, Canada
-
Mahidol UniversityRecruitingSpinal Cord Injury | Incomplete Spinal Cord InjuryThailand
Clinical Trials on Measurement of interface pressure
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Abant Izzet Baysal UniversityCompletedBreast Cancer Lymphedema | Lymphedema of Upper Limb | Edema ArmTurkey
-
ThuasneCompletedRisk of Venous ThrombosisFrance
-
University Hospital OstravaCompletedCompartment Syndromes | Burn Injury | PolytraumaCzechia
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Jordi Gol i Gurina FoundationInstitut Catala de SalutCompleted
-
RWTH Aachen UniversityCompleted
-
University Magna GraeciaUnknownFunctional Evaluation of Non Culprit Lesions in ACS PatientsItaly
-
Policlinico HospitalCompletedCritically Ill PatientsItaly
-
Kaiser PermanentePatient-Centered Outcomes Research InstituteCompleted